1373223-18-7 Usage
Description
Tert-Butyl (2-chloro-6-(trifluoromethyl)pyridin-4-yl)carbamate is a chemical compound with the formula C13H14ClF3N2O2. It is a white crystalline solid that is commonly used as a reagent in organic synthesis. tert-Butyl (2-chloro-6-(trifluoromethyl)pyridin-4-yl)carbamate features a tert-butyl group attached to a carbamate moiety and a pyridine ring with a chlorine and trifluoromethyl substituent. Its unique structure and functional groups have attracted interest for potential applications in pharmaceuticals and agrochemicals.
Uses
Used in Pharmaceutical Industry:
Tert-Butyl (2-chloro-6-(trifluoromethyl)pyridin-4-yl)carbamate is used as a reagent in the synthesis of pharmaceutical compounds due to its unique structure and functional groups. Its properties can be leveraged to create new drugs with specific therapeutic effects.
Used in Agrochemical Industry:
In the agrochemical field, tert-Butyl (2-chloro-6-(trifluoromethyl)pyridin-4-yl)carbamate is used as a reagent for the development of new agrochemicals. Its chemical properties can contribute to the creation of effective pesticides or other agricultural products.
It is important to handle and use this compound with care, following proper safety protocols and guidelines for handling hazardous chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 1373223-18-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,7,3,2,2 and 3 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1373223-18:
(9*1)+(8*3)+(7*7)+(6*3)+(5*2)+(4*2)+(3*3)+(2*1)+(1*8)=137
137 % 10 = 7
So 1373223-18-7 is a valid CAS Registry Number.
1373223-18-7Relevant articles and documents
CYCLIC COMPOUNDS AND METHODS OF USING SAME
-
Page/Page column 359-360, (2021/07/02)
The present application relates to compounds of Formula (I), as defined herein, and pharmaceutically acceptable salts thereof which are MALT1 inhibitors. The present application also describes pharmaceutical composition comprising a compound of Formula (I), and pharmaceutically acceptable salts thereof, and methods of using the compounds and compositions for treating diseases, such as cancer, autoimmune disorders, and inflammatory disorders.
